Related Experiment Video

Updated: May 16, 2026

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

[Management of atrioventricular conduction abnormalities in myotonic dystrophy]

Takuhisa Tamura1

  • 1Department of Neurology, National Hospital Organization Higashisaitama Hospital.

Rinsho Shinkeigaku = Clinical Neurology
|December 1, 2012
PubMed

Insights

Sudden cardiac death is a risk for myotonic dystrophy patients due to heart rhythm issues. Noninvasive His-ventricle (HV) interval measurement aids in assessing risk and guiding pacemaker implantation decisions.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Genetics

Context:

  • Myotonic dystrophy (DM) patients face a high risk of sudden cardiac death, often linked to atrioventricular blocks (AVBs) and tachyarrhythmias.
  • His-Purkinje system abnormalities are implicated in AVBs, with QRS width and electrical axis deviation serving as important indicators.
  • The His-ventricle (HV) interval is crucial for detecting His-Purkinje system abnormalities in cardiac electrophysiological testing.

Purpose:

  • To noninvasively measure the His-ventricle (HV) interval (BHV) using signal-averaged electrocardiogram (SAECG) to assess His-Purkinje system function.
  • To investigate the correlation between the noninvasively measured BHV and electrocardiographic parameters like QRS width and electrical axis.
  • To inform the clinical decision-making process regarding pacemaker implantation (PMI) in myotonic dystrophy patients.

Summary:

  • The study successfully measured the BHV noninvasively and found significant correlations between BHV, QRS width, and electrical axis deviation.
  • Despite guidelines, prophylactic PMI in asymptomatic DM patients with prolonged HV intervals (>70 ms) and severe muscle involvement did not consistently improve prognosis.
  • The findings emphasize the need for individualized assessment of PMI indications, considering both cardiac and extra-cardiac factors.

Impact:

  • Provides a noninvasive method for evaluating cardiac conduction abnormalities in myotonic dystrophy, potentially reducing the need for invasive electrophysiological studies.
  • Highlights the limitations of solely relying on HV interval measurements for pacemaker implantation decisions in specific patient subgroups.
  • Encourages a comprehensive approach to managing cardiac risks in myotonic dystrophy, balancing prophylactic interventions with individual prognosis and complications.

More Related Videos

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

Isolation of Atrial Myocytes from Adult Mice08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...